BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12458403)

  • 1. Dysregulation of coronary microvascular reactivity in asymptomatic patients with type 2 diabetes mellitus.
    Momose M; Abletshauser C; Neverve J; Nekolla SG; Schnell O; Standl E; Schwaiger M; Bengel FM
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1675-9. PubMed ID: 12458403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of myocardial microvascular disease using contrast echocardiography during adenosine stress in type 2 diabetes mellitus: prospective comparison with single-photon emission computed tomography.
    Abdelmoneim SS; Basu A; Bernier M; Dhoble A; Abdel-Kader SS; Pellikka PA; Mulvagh SL
    Diab Vasc Dis Res; 2011 Oct; 8(4):254-61. PubMed ID: 21933841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes.
    Di Carli MF; Janisse J; Grunberger G; Ager J
    J Am Coll Cardiol; 2003 Apr; 41(8):1387-93. PubMed ID: 12706936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes.
    Kjaer A; Meyer C; Nielsen FS; Parving HH; Hesse B
    J Nucl Med; 2003 Jan; 44(1):19-23. PubMed ID: 12515871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deferoxamine improves coronary vascular responses to sympathetic stimulation in patients with type 1 diabetes mellitus.
    Hattori N; Schnell O; Bengel FM; Rihl J; Nekolla SG; Drzezga AE; Standl E; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):891-8. PubMed ID: 12111129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes.
    Schindler TH; Facta AD; Prior JO; Cadenas J; Hsueh WA; Quinones MJ; Schelbert HR
    Heart; 2007 Mar; 93(3):345-9. PubMed ID: 16940388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of type 2 diabetes mellitus on epicardial adipose tissue volume and coronary vasomotor function.
    Chen WJ; Danad I; Raijmakers PG; Halbmeijer R; Harms HJ; Lammertsma AA; van Rossum AC; Diamant M; Knaapen P
    Am J Cardiol; 2014 Jan; 113(1):90-7. PubMed ID: 24169015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes mellitus and coronary microvascular function in asymptomatic patients with severe aortic stenosis and nonobstructed coronary arteries.
    Banovic M; Brkovic V; Nedeljkovic I; Nedeljkovic M; Popovic D; Djordjevic-Dikic A; Ristic A; Nikolic S; Beleslin B
    Diab Vasc Dis Res; 2016 May; 13(3):220-7. PubMed ID: 26993497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased endothelium-dependent coronary vasomotion in healthy young smokers.
    Iwado Y; Yoshinaga K; Furuyama H; Ito Y; Noriyasu K; Katoh C; Kuge Y; Tsukamoto E; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):984-90. PubMed ID: 12173010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive study of coronary microcirculation response to a cold pressor test.
    Pham I; Nguyen MT; Valensi P; Rousseau H; Nitenberg A; Vicaut E; Cosson E
    Eur J Clin Invest; 2015 Feb; 45(2):135-43. PubMed ID: 25490913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of myocardial blood flow response to cold pressor testing and pharmacologic vasodilation in healthy humans.
    Prior JO; Schindler TH; Facta AD; Hernandez-Pampaloni M; Campisi R; Dahlbom M; Schelbert HR
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):20-7. PubMed ID: 16902794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dysfunction of the coronary microcirculation in type 2 diabetic patients].
    Nitenberg A; Ledoux S; Valensi P; Sachs R; Attali JR; Antony I
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):937-41. PubMed ID: 10989733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary vascular dysfunction in premenopausal women with diabetes mellitus.
    Di Carli MF; Afonso L; Campisi R; Ramappa P; Bianco-Batlles D; Grunberger G; Schelbert HR
    Am Heart J; 2002 Oct; 144(4):711-8. PubMed ID: 12360169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nateglinide on myocardial microvascular reactivity in Type 2 diabetes mellitus--a randomized study using positron emission tomography.
    Bengel FM; Abletshauser C; Neverve J; Schnell O; Nekolla SG; Standl E; Schwaiger M
    Diabet Med; 2005 Feb; 22(2):158-63. PubMed ID: 15660732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary microangiopathy in type 2 diabetic patients: relation to glycemic control, sex, and microvascular angina rather than to coronary artery disease.
    Yokoyama I; Yonekura K; Ohtake T; Yang W; Shin WS; Yamada N; Ohtomo K; Nagai R
    J Nucl Med; 2000 Jun; 41(6):978-85. PubMed ID: 10855621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bimodal Pattern of Coronary Microvascular Involvement in Diabetes Mellitus.
    Sezer M; Kocaaga M; Aslanger E; Atici A; Demirkiran A; Bugra Z; Umman S; Umman B
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27930353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women.
    Martin JW; Briesmiester K; Bargardi A; Muzik O; Mosca L; Duvernoy CS
    Clin Cardiol; 2005 Jan; 28(1):13-8. PubMed ID: 15704526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography.
    Schindler TH; Nitzsche EU; Olschewski M; Brink I; Mix M; Prior J; Facta A; Inubushi M; Just H; Schelbert HR
    J Nucl Med; 2004 Mar; 45(3):419-28. PubMed ID: 15001682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary microvascular adaptation to myocardial metabolic demand can be restored by inhibition of iron-catalyzed formation of oxygen free radicals in type 2 diabetic patients.
    Nitenberg A; Ledoux S; Valensi P; Sachs R; Antony I
    Diabetes; 2002 Mar; 51(3):813-8. PubMed ID: 11872685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus.
    Schindler TH; Facta AD; Prior JO; Cadenas J; Zhang XL; Li Y; Sayre J; Goldin J; Schelbert HR
    Eur J Nucl Med Mol Imaging; 2009 Feb; 36(2):219-29. PubMed ID: 18704406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.